_id

695fb0c2c2e91020a7bd40a0

Ticker

0A2V.LSE

Name

Sanofi

Exchange

LSE

Address

46, avenue de la Grande Armée, Paris, France, 75017

Country

UK

Sector

Industry

Currency

USD

Website

https://www.sanofi.com

Description

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; influenza, booster, meningitis, and travel and endemic vaccines, that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Innate Pharma SA for a natural killer cell engager program targeting B7-H3; and Blackstone Life Sciences to develop pivotal studies and clinical development program. Further, it has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop novel targeted protein degradation therapies; Denali Therapeutics Inc. to treat a range of systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for the discovery and development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab, as well as a strategic alliance with the Department of Health " Abu Dhabi for the development of global vaccines. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

Last Close

48.31

Volume

400

Current Price

48.31

Change

0.0014

Last Updated

2026-01-08T13:27:30.290Z

Ipo Date

-

Market Cap

-

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-

Sentiment Sources

0

Current Quarter

2025-09-30

Revenue

13170000000

Cost Of Revenue

3412000000

Gross Profit

9758000000

Operating Expenses

9385000000

Operating Income

3785000000

Interest Expense

227000000

Pretax Income

3510000000

Net Income

2802000000

Eps

2.3005148548139944

Dividends Per Share

-

Shares Outstanding

2433679872

Income Tax Expense

-

EBITDA

-

Operating Margin

28.73955960516325

Total Other Income Expense Net

-161000000

Cash

8906000000

Short Term Investments

-

Receivables

-

Inventories

24501000000

Total Current Assets

34042000000

Property Plant Equipment

11181000000

Total Assets

129794000000

Payables

22000000000

Short Term Debt

-

Long Term Debt

11700000000

Total Liabilities

56261000000

Equity

73263000000

Bs_currency_symbol

EUR

Depreciation

-

Change In Working Capital

-

Cash From Operations

3750000000

Capital Expenditures

0

Cash From Investing

-

Cash From Financing

-1148000000

Net Change In Cash

-6453000000

Cf_currency_symbol

EUR

PE

0.1678

PB

0.8031477151240053

ROE

3.8245772081405347

ROA

2.158805491779281

FCF

3750000000

Fcf Percent

0.2847380410022779

Piotroski FScore

4

Health Score

69

Deep Value Investing Score

7.5

Defensive Investing Score

6

Dividend Investing Score

3

Economic Moat Investing Score

8.3

Garp Investing Score

5

Growth Investing Score

4.5

Momentum Investing Score

4

Net Net Investing Score

3.5

Quality Investing Score

8

Value Investing Score

9

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

13170000000

Quarters > 0 > income Statement > cost Of Revenue

3412000000

Quarters > 0 > income Statement > gross Profit

9758000000

Quarters > 0 > income Statement > operating Expenses

9385000000

Quarters > 0 > income Statement > operating Income

3785000000

Quarters > 0 > income Statement > interest Expense

227000000

Quarters > 0 > income Statement > pretax Income

3510000000

Quarters > 0 > income Statement > net Income

2802000000

Quarters > 0 > income Statement > eps

2.3005148548139944

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

1217988223

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-

Quarters > 0 > income Statement > operating Margin

28.73955960516325

Quarters > 0 > income Statement > total Other Income Expense Net

-161000000

Quarters > 0 > income Statement > currency_symbol

EUR

Quarters > 0 > balance Sheet > cash

8906000000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

24501000000

Quarters > 0 > balance Sheet > total Current Assets

34042000000

Quarters > 0 > balance Sheet > property Plant Equipment

11181000000

Quarters > 0 > balance Sheet > total Assets

129794000000

Quarters > 0 > balance Sheet > payables

22000000000

Quarters > 0 > balance Sheet > short Term Debt

-

Quarters > 0 > balance Sheet > long Term Debt

11700000000

Quarters > 0 > balance Sheet > total Liabilities

56261000000

Quarters > 0 > balance Sheet > equity

73263000000

Quarters > 0 > balance Sheet > currency_symbol

EUR

Quarters > 0 > cash Flow > net Income

2802000000

Quarters > 0 > cash Flow > depreciation

-

Quarters > 0 > cash Flow > change In Working Capital

-

Quarters > 0 > cash Flow > cash From Operations

3750000000

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

-1148000000

Quarters > 0 > cash Flow > net Change In Cash

-6453000000

Quarters > 0 > cash Flow > currency_symbol

EUR

Quarters > 0 > ratios > PE

2.3005148548139944

Quarters > 0 > ratios > PB

0.8031477151240053

Quarters > 0 > ratios > ROE

3.8245772081405347

Quarters > 0 > ratios > ROA

2.158805491779281

Quarters > 0 > ratios > FCF

3750000000

Quarters > 0 > ratios > Piotroski FScore

4

Quarters > 0 > ratios > fcf Percent

0.2847380410022779

Quarters > 0 > health Score

69

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

10735000000

Quarters > 1 > income Statement > cost Of Revenue

2992000000

Quarters > 1 > income Statement > gross Profit

7743000000

Quarters > 1 > income Statement > operating Expenses

9023000000

Quarters > 1 > income Statement > operating Income

1712000000

Quarters > 1 > income Statement > interest Expense

87000000

Quarters > 1 > income Statement > pretax Income

1424000000

Quarters > 1 > income Statement > net Income

3940000000

Quarters > 1 > income Statement > eps

3.237202634674104

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

1217100208

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-

Quarters > 1 > income Statement > operating Margin

15.947834187238005

Quarters > 1 > income Statement > total Other Income Expense Net

-237000000

Quarters > 1 > income Statement > currency_symbol

EUR

Quarters > 1 > balance Sheet > cash

15359000000

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

7810000000

Quarters > 1 > balance Sheet > inventories

9618000000

Quarters > 1 > balance Sheet > total Current Assets

37017000000

Quarters > 1 > balance Sheet > property Plant Equipment

11007000000

Quarters > 1 > balance Sheet > total Assets

124959000000

Quarters > 1 > balance Sheet > payables

7075000000

Quarters > 1 > balance Sheet > short Term Debt

-

Quarters > 1 > balance Sheet > long Term Debt

13200000000

Quarters > 1 > balance Sheet > total Liabilities

54680000000

Quarters > 1 > balance Sheet > equity

70008000000

Quarters > 1 > balance Sheet > currency_symbol

EUR

Quarters > 1 > cash Flow > net Income

3939000000

Quarters > 1 > cash Flow > depreciation

-

Quarters > 1 > cash Flow > change In Working Capital

-

Quarters > 1 > cash Flow > cash From Operations

1462000000

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

-

Quarters > 1 > cash Flow > cash From Financing

-3857000000

Quarters > 1 > cash Flow > net Change In Cash

7368000000

Quarters > 1 > cash Flow > currency_symbol

EUR

Quarters > 1 > ratios > PE

3.237202634674104

Quarters > 1 > ratios > PB

0.8398770290321106

Quarters > 1 > ratios > ROE

5.627928236772941

Quarters > 1 > ratios > ROA

3.1530341952160303

Quarters > 1 > ratios > FCF

1462000000

Quarters > 1 > ratios > Piotroski FScore

3

Quarters > 1 > ratios > fcf Percent

0.13619003260363297

Quarters > 1 > health Score

64

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

10606000000

Quarters > 2 > income Statement > cost Of Revenue

2889000000

Quarters > 2 > income Statement > gross Profit

7717000000

Quarters > 2 > income Statement > operating Expenses

8145000000

Quarters > 2 > income Statement > operating Income

2461000000

Quarters > 2 > income Statement > interest Expense

213000000

Quarters > 2 > income Statement > pretax Income

2158000000

Quarters > 2 > income Statement > net Income

1872000000

Quarters > 2 > income Statement > eps

1.5363190400479867

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

1218496908

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-

Quarters > 2 > income Statement > operating Margin

23.203846879125024

Quarters > 2 > income Statement > total Other Income Expense Net

-176000000

Quarters > 2 > income Statement > currency_symbol

EUR

Quarters > 2 > balance Sheet > cash

7991000000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

-

Quarters > 2 > balance Sheet > inventories

21850000000

Quarters > 2 > balance Sheet > total Current Assets

44019000000

Quarters > 2 > balance Sheet > property Plant Equipment

11352000000

Quarters > 2 > balance Sheet > total Assets

131892000000

Quarters > 2 > balance Sheet > payables

21616000000

Quarters > 2 > balance Sheet > short Term Debt

-

Quarters > 2 > balance Sheet > long Term Debt

11767000000

Quarters > 2 > balance Sheet > total Liabilities

57474000000

Quarters > 2 > balance Sheet > equity

74074000000

Quarters > 2 > balance Sheet > currency_symbol

EUR

Quarters > 2 > cash Flow > net Income

1872000000

Quarters > 2 > cash Flow > depreciation

-

Quarters > 2 > cash Flow > change In Working Capital

-

Quarters > 2 > cash Flow > cash From Operations

2093000000

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

-

Quarters > 2 > cash Flow > cash From Financing

-584000000

Quarters > 2 > cash Flow > net Change In Cash

550000000

Quarters > 2 > cash Flow > currency_symbol

EUR

Quarters > 2 > ratios > PE

1.5363190400479867

Quarters > 2 > ratios > PB

0.7946862006301807

Quarters > 2 > ratios > ROE

2.527202527202527

Quarters > 2 > ratios > ROA

1.4193430988990994

Quarters > 2 > ratios > FCF

2093000000

Quarters > 2 > ratios > Piotroski FScore

4

Quarters > 2 > ratios > fcf Percent

0.19734112766358666

Quarters > 2 > health Score

67

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

7631000000

Quarters > 3 > income Statement > cost Of Revenue

2271000000

Quarters > 3 > income Statement > gross Profit

5360000000

Quarters > 3 > income Statement > operating Expenses

6770000000

Quarters > 3 > income Statement > operating Income

861000000

Quarters > 3 > income Statement > interest Expense

102000000

Quarters > 3 > income Statement > pretax Income

456000000

Quarters > 3 > income Statement > net Income

499000000

Quarters > 3 > income Statement > eps

0.3980562601709756

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

1253591640

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-

Quarters > 3 > income Statement > operating Margin

11.282924911545015

Quarters > 3 > income Statement > total Other Income Expense Net

-282000000

Quarters > 3 > income Statement > currency_symbol

EUR

Quarters > 3 > balance Sheet > cash

7441000000

Quarters > 3 > balance Sheet > short Term Investments

486000000

Quarters > 3 > balance Sheet > receivables

7677000000

Quarters > 3 > balance Sheet > inventories

9431000000

Quarters > 3 > balance Sheet > total Current Assets

42588000000

Quarters > 3 > balance Sheet > property Plant Equipment

11601000000

Quarters > 3 > balance Sheet > total Assets

132798000000

Quarters > 3 > balance Sheet > payables

7551000000

Quarters > 3 > balance Sheet > short Term Debt

-

Quarters > 3 > balance Sheet > long Term Debt

11791000000

Quarters > 3 > balance Sheet > total Liabilities

54941000000

Quarters > 3 > balance Sheet > equity

77507000000

Quarters > 3 > balance Sheet > currency_symbol

EUR

Quarters > 3 > cash Flow > net Income

683000000

Quarters > 3 > cash Flow > depreciation

-

Quarters > 3 > cash Flow > change In Working Capital

-

Quarters > 3 > cash Flow > cash From Operations

-

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

-

Quarters > 3 > cash Flow > cash From Financing

-

Quarters > 3 > cash Flow > net Change In Cash

-

Quarters > 3 > cash Flow > currency_symbol

EUR

Quarters > 3 > ratios > PE

0.3980562601709756

Quarters > 3 > ratios > PB

0.7813618399421988

Quarters > 3 > ratios > ROE

0.64381281690686

Quarters > 3 > ratios > ROA

0.37575867106432326

Quarters > 3 > ratios > FCF

-

Quarters > 3 > ratios > Piotroski FScore

2

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

53

Annuals > 0 > quarter

2024-12-31

Annuals > 0 > income Statement > revenue

44286000000

Annuals > 0 > income Statement > cost Of Revenue

13205000000

Annuals > 0 > income Statement > gross Profit

31081000000

Annuals > 0 > income Statement > operating Expenses

34824000000

Annuals > 0 > income Statement > operating Income

9462000000

Annuals > 0 > income Statement > interest Expense

749000000

Annuals > 0 > income Statement > pretax Income

6698000000

Annuals > 0 > income Statement > net Income

5560000000

Annuals > 0 > income Statement > eps

4.435256125351953

Annuals > 0 > income Statement > dividends Per Share

4704000000

Annuals > 0 > income Statement > shares Outstanding

1253591640

Annuals > 0 > income Statement > income Tax Expense

-

Annuals > 0 > income Statement > EBITDA

-

Annuals > 0 > income Statement > operating Margin

21.365668608589623

Annuals > 0 > income Statement > total Other Income Expense Net

-2204000000

Annuals > 0 > income Statement > currency_symbol

EUR

Annuals > 0 > balance Sheet > cash

7441000000

Annuals > 0 > balance Sheet > short Term Investments

486000000

Annuals > 0 > balance Sheet > receivables

7677000000

Annuals > 0 > balance Sheet > inventories

9431000000

Annuals > 0 > balance Sheet > total Current Assets

42588000000

Annuals > 0 > balance Sheet > property Plant Equipment

11601000000

Annuals > 0 > balance Sheet > total Assets

132798000000

Annuals > 0 > balance Sheet > payables

7551000000

Annuals > 0 > balance Sheet > short Term Debt

-

Annuals > 0 > balance Sheet > long Term Debt

11791000000

Annuals > 0 > balance Sheet > total Liabilities

54941000000

Annuals > 0 > balance Sheet > equity

77507000000

Annuals > 0 > balance Sheet > currency_symbol

EUR

Annuals > 0 > cash Flow > net Income

5560000000

Annuals > 0 > cash Flow > depreciation

3586000000

Annuals > 0 > cash Flow > change In Working Capital

-615000000

Annuals > 0 > cash Flow > cash From Operations

9081000000

Annuals > 0 > cash Flow > capital Expenditures

3195000000

Annuals > 0 > cash Flow > cash From Investing

-

Annuals > 0 > cash Flow > cash From Financing

-5751000000

Annuals > 0 > cash Flow > net Change In Cash

-1269000000

Annuals > 0 > cash Flow > currency_symbol

EUR

Annuals > 0 > ratios > PE

4.435256125351953

Annuals > 0 > ratios > PB

0.7813618399421988

Annuals > 0 > ratios > ROE

7.173545615234753

Annuals > 0 > ratios > ROA

4.186810042319915

Annuals > 0 > ratios > FCF

5886000000

Annuals > 0 > ratios > Piotroski FScore

4

Annuals > 0 > ratios > fcf Percent

0.13290881994309714

Annuals > 0 > health Score

67

Annuals > 1 > quarter

2023-12-31

Annuals > 1 > income Statement > revenue

41618000000

Annuals > 1 > income Statement > cost Of Revenue

12628000000

Annuals > 1 > income Statement > gross Profit

28990000000

Annuals > 1 > income Statement > operating Expenses

32443000000

Annuals > 1 > income Statement > operating Income

9175000000

Annuals > 1 > income Statement > interest Expense

710000000

Annuals > 1 > income Statement > pretax Income

6251000000

Annuals > 1 > income Statement > net Income

5400000000

Annuals > 1 > income Statement > eps

4.31534087835364

Annuals > 1 > income Statement > dividends Per Share

4454000000

Annuals > 1 > income Statement > shares Outstanding

1251349581

Annuals > 1 > income Statement > income Tax Expense

-

Annuals > 1 > income Statement > EBITDA

-

Annuals > 1 > income Statement > operating Margin

22.04574943534048

Annuals > 1 > income Statement > total Other Income Expense Net

-2218000000

Annuals > 1 > income Statement > currency_symbol

EUR

Annuals > 1 > balance Sheet > cash

8710000000

Annuals > 1 > balance Sheet > short Term Investments

270000000

Annuals > 1 > balance Sheet > receivables

8433000000

Annuals > 1 > balance Sheet > inventories

9666000000

Annuals > 1 > balance Sheet > total Current Assets

30670000000

Annuals > 1 > balance Sheet > property Plant Equipment

11814000000

Annuals > 1 > balance Sheet > total Assets

126464000000

Annuals > 1 > balance Sheet > payables

7328000000

Annuals > 1 > balance Sheet > short Term Debt

-

Annuals > 1 > balance Sheet > long Term Debt

14347000000

Annuals > 1 > balance Sheet > total Liabilities

52111000000

Annuals > 1 > balance Sheet > equity

74040000000

Annuals > 1 > balance Sheet > currency_symbol

EUR

Annuals > 1 > cash Flow > net Income

5400000000

Annuals > 1 > cash Flow > depreciation

4429000000

Annuals > 1 > cash Flow > change In Working Capital

413000000

Annuals > 1 > cash Flow > cash From Operations

10258000000

Annuals > 1 > cash Flow > capital Expenditures

2906000000

Annuals > 1 > cash Flow > cash From Investing

-

Annuals > 1 > cash Flow > cash From Financing

-8048000000

Annuals > 1 > cash Flow > net Change In Cash

-4026000000

Annuals > 1 > cash Flow > currency_symbol

EUR

Annuals > 1 > ratios > PE

4.31534087835364

Annuals > 1 > ratios > PB

0.8164870105093193

Annuals > 1 > ratios > ROE

7.293354943273905

Annuals > 1 > ratios > ROA

4.26998987854251

Annuals > 1 > ratios > FCF

7352000000

Annuals > 1 > ratios > Piotroski FScore

3

Annuals > 1 > ratios > fcf Percent

0.17665433226007976

Annuals > 1 > health Score

71

Annuals > 2 > quarter

2022-12-31

Annuals > 2 > income Statement > revenue

40561000000

Annuals > 2 > income Statement > cost Of Revenue

11882000000

Annuals > 2 > income Statement > gross Profit

28679000000

Annuals > 2 > income Statement > operating Expenses

29635000000

Annuals > 2 > income Statement > operating Income

10926000000

Annuals > 2 > income Statement > interest Expense

465000000

Annuals > 2 > income Statement > pretax Income

9937000000

Annuals > 2 > income Statement > net Income

8371000000

Annuals > 2 > income Statement > eps

6.639247118037736

Annuals > 2 > income Statement > dividends Per Share

4168000000

Annuals > 2 > income Statement > shares Outstanding

1260835732

Annuals > 2 > income Statement > income Tax Expense

-

Annuals > 2 > income Statement > EBITDA

-

Annuals > 2 > income Statement > operating Margin

26.937205690195015

Annuals > 2 > income Statement > total Other Income Expense Net

-766000000

Annuals > 2 > income Statement > currency_symbol

EUR

Annuals > 2 > balance Sheet > cash

12736000000

Annuals > 2 > balance Sheet > short Term Investments

663000000

Annuals > 2 > balance Sheet > receivables

8424000000

Annuals > 2 > balance Sheet > inventories

8960000000

Annuals > 2 > balance Sheet > total Current Assets

34110000000

Annuals > 2 > balance Sheet > property Plant Equipment

11684000000

Annuals > 2 > balance Sheet > total Assets

126722000000

Annuals > 2 > balance Sheet > payables

6813000000

Annuals > 2 > balance Sheet > short Term Debt

-

Annuals > 2 > balance Sheet > long Term Debt

14857000000

Annuals > 2 > balance Sheet > total Liabilities

51570000000

Annuals > 2 > balance Sheet > equity

74784000000

Annuals > 2 > balance Sheet > currency_symbol

EUR

Annuals > 2 > cash Flow > net Income

6720000000

Annuals > 2 > cash Flow > depreciation

3108000000

Annuals > 2 > cash Flow > change In Working Capital

-794000000

Annuals > 2 > cash Flow > cash From Operations

10526000000

Annuals > 2 > cash Flow > capital Expenditures

2103000000

Annuals > 2 > cash Flow > cash From Investing

-

Annuals > 2 > cash Flow > cash From Financing

-5807000000

Annuals > 2 > cash Flow > net Change In Cash

2638000000

Annuals > 2 > cash Flow > currency_symbol

EUR

Annuals > 2 > ratios > PE

6.639247118037736

Annuals > 2 > ratios > PB

0.8144920599716517

Annuals > 2 > ratios > ROE

11.19357081728712

Annuals > 2 > ratios > ROA

6.605798519594072

Annuals > 2 > ratios > FCF

8423000000

Annuals > 2 > ratios > Piotroski FScore

3

Annuals > 2 > ratios > fcf Percent

0.20766253297502527

Annuals > 2 > health Score

78

Annuals > 3 > quarter

2021-12-31

Annuals > 3 > income Statement > revenue

39175000000

Annuals > 3 > income Statement > cost Of Revenue

12255000000

Annuals > 3 > income Statement > gross Profit

26920000000

Annuals > 3 > income Statement > operating Expenses

30028000000

Annuals > 3 > income Statement > operating Income

9147000000

Annuals > 3 > income Statement > interest Expense

389000000

Annuals > 3 > income Statement > pretax Income

7798000000

Annuals > 3 > income Statement > net Income

6223000000

Annuals > 3 > income Statement > eps

4.968301648674178

Annuals > 3 > income Statement > dividends Per Share

4008000000

Annuals > 3 > income Statement > shares Outstanding

1252540695

Annuals > 3 > income Statement > income Tax Expense

-

Annuals > 3 > income Statement > EBITDA

-

Annuals > 3 > income Statement > operating Margin

23.3490746649649

Annuals > 3 > income Statement > total Other Income Expense Net

-979000000

Annuals > 3 > income Statement > currency_symbol

EUR

Annuals > 3 > balance Sheet > cash

10098000000

Annuals > 3 > balance Sheet > short Term Investments

1054000000

Annuals > 3 > balance Sheet > receivables

7568000000

Annuals > 3 > balance Sheet > inventories

8715000000

Annuals > 3 > balance Sheet > total Current Assets

30653000000

Annuals > 3 > balance Sheet > property Plant Equipment

11976000000

Annuals > 3 > balance Sheet > total Assets

120242000000

Annuals > 3 > balance Sheet > payables

6180000000

Annuals > 3 > balance Sheet > short Term Debt

-

Annuals > 3 > balance Sheet > long Term Debt

17123000000

Annuals > 3 > balance Sheet > total Liabilities

51211000000

Annuals > 3 > balance Sheet > equity

68681000000

Annuals > 3 > balance Sheet > currency_symbol

EUR

Annuals > 3 > cash Flow > net Income

6223000000

Annuals > 3 > cash Flow > depreciation

3351000000

Annuals > 3 > cash Flow > change In Working Capital

1409000000

Annuals > 3 > cash Flow > cash From Operations

10522000000

Annuals > 3 > cash Flow > capital Expenditures

2043000000

Annuals > 3 > cash Flow > cash From Investing

-

Annuals > 3 > cash Flow > cash From Financing

-7056000000

Annuals > 3 > cash Flow > net Change In Cash

-3817000000

Annuals > 3 > cash Flow > currency_symbol

EUR

Annuals > 3 > ratios > PE

4.968301648674178

Annuals > 3 > ratios > PB

0.8810331965965843

Annuals > 3 > ratios > ROE

9.060730041787394

Annuals > 3 > ratios > ROA

5.175396284160277

Annuals > 3 > ratios > FCF

8479000000

Annuals > 3 > ratios > Piotroski FScore

3

Annuals > 3 > ratios > fcf Percent

0.21643905552010212

Annuals > 3 > health Score

75

Valuation > metrics > PE

0.1678

Valuation > metrics > PB

0.8031477151240053

Valuation > final Score

90

Valuation > verdict

59.0% Undervalued

Profitability > metrics > ROE

3.8245772081405347

Profitability > metrics > ROA

8.231008753892251

Profitability > metrics > Net Margin

0.21275626423690205

Profitability > final Score

62

Profitability > verdict

Adequate

Risk > metrics > Debt Equity

0.7679319711177538

Risk > metrics > Interest Coverage

16.674008810572687

Risk > final Score

88

Risk > verdict

Low

Liquidity > metrics > Current Ratio

1.5473636363636363

Liquidity > metrics > Quick Ratio

0.43368181818181817

Liquidity > final Score

60

Liquidity > verdict

Weak

Prev Valuations > 0

90

Prev Valuations > 1

90

Prev Valuations > 2

90

Prev Profitabilities > 0

71

Prev Profitabilities > 1

44

Prev Profitabilities > 2

15

Prev Risks > 0

88

Prev Risks > 1

88

Prev Risks > 2

82

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2026-01-20T23:13:04.932Z

Earnings History > 0 > period

2025-12-31

Earnings History > 0 > report Date

2026-01-29

Earnings History > 0 > date

2025-12-31

Earnings History > 0 > before After Market

BeforeMarket

Earnings History > 0 > currency

-

Earnings History > 0 > eps Actual

-

Earnings History > 0 > eps Estimate

0.81

Earnings History > 0 > eps Difference

0

Earnings History > 0 > surprise Percent

-